BioSpace x DIA: Robust Integrated Regulatory Strategies
06 Jun 2024
21m
BioSpace · Business
BioSpace
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Episodes
The ABCs of Biopharma This Week: ASCO, BIO and Cancer
05 Jun 2024
12m
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion
30 May 2024
18m
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO
28 May 2024
13m
BioSpace x DIA: Navigating the Emergence of CGT Combination Products
23 May 2024
20m
Bayer’s New Strategy, Novo Vs. Lilly and Psychedelics
22 May 2024
13m
Bayer Layoffs, a Big Alzheimer’s Deal and ASGCT Wrap
15 May 2024
14m
Women's Health: Where Politics and Science Meet
09 May 2024
21m
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird
08 May 2024
11m
BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy
03 May 2024
12m
The IRA, BMS’ Big Cuts, First WHIM Approval
01 May 2024
15m
Where Do We Go From Here? The Future of Women's Health
25 Apr 2024
22m
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
24 Apr 2024
17m
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages
17 Apr 2024
20m
It's a Design Problem: Women and Clinical Trials
11 Apr 2024
19m
Alphabet Soup: AACR and ACC Dominate Headlines This Week
10 Apr 2024
16m
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo
03 Apr 2024
11m
Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of Helping Patients?
28 Mar 2024
22m
Bayer’s sweeping executive cuts, Wegovy’s expanding reach
27 Mar 2024
16m
Money talk: Salary trends and raises
21 Mar 2024
15m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.